AZ, Daiichi HER-2 drug shows promise in mid-stage trial

9th May 2019 Uncategorised 0

Approximately one in five breast cancers are HER2-positive, meaning there is an unmet need for treatments.

More: AZ, Daiichi HER-2 drug shows promise in mid-stage trial
Source: News